Literature DB >> 33625065

Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV.

Sean G Kelly1, Kunling Wu2, Katherine Tassiopoulos2, Kristine M Erlandson3, Susan L Koletar4, Frank J Palella5.   

Abstract

BACKGROUND: The 2013 Pooled Cohort Equations (PCEs) have underestimated cardiovascular disease (CVD) events among persons with HIV (PWH). We evaluate whether the addition of frailty improves PCE's ability to estimate CVD risk among aging PWH.
SETTING: Multicenter study.
METHODS: We assessed baseline frailty and 5-year atherosclerotic CVD risk using PCEs for participants in the AIDS Clinical Trials Group A5322 observational study. The primary outcome was incident CVD. We fit Cox proportional hazards regression models for incident CVD with (1) PCEs alone and (2) PCEs and frailty together (which included separate models for frailty score, frailty status, slow gait speed, and weak grip strength). We evaluated discrimination ability for the models with and without frailty by comparing their areas under receiver operating characteristic curve (AUCs) and Uno C-statistics, as well as by calculating the net reclassification improvement and integrated discrimination improvement.
RESULTS: The analysis included 944 A5322 participants (759 men, 185 women, median age 50 years, 47% White non-Hispanic). Thirty-nine participants experienced incident CVD during the study period. PCEs predicted 5-year CVD risk in all models. With frailty score, frailty status, slow gait speed, or weak grip strength added, the AUC and C-statistics were relatively unchanged, and the NRI and integrated discrimination improvement indicated little improvement in model discrimination. However, frailty score independently predicted CVD risk [frailty score: hazard ratio = 1.30, 95% confidence interval (CI) = 1.00 to 1.70, P = 0.05].
CONCLUSIONS: Frailty did not improve the predictive ability of PCEs. Baseline PCEs and frailty score independently predicted CVD. Incorporation of frailty assessment into clinical practice may provide corroborative and independent CVD risk estimation.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33625065      PMCID: PMC8192418          DOI: 10.1097/QAI.0000000000002662

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  44 in total

1.  Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.

Authors:  Rebeccah A McKibben; Joseph B Margolick; Steven Grinspoon; Xiuhong Li; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Richard T George; Lisa P Jacobson; Matthew Budoff; Russell P Tracy; Todd T Brown; Wendy S Post
Journal:  J Infect Dis       Date:  2014-10-30       Impact factor: 5.226

2.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

3.  Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus.

Authors:  Kristine M Erlandson; Jeremiah Perez; Mona Abdo; Kevin Robertson; Ronald J Ellis; Susan L Koletar; Robert Kalayjian; Babafemi Taiwo; Frank J Palella; Katherine Tassiopoulos
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

4.  Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study.

Authors:  Joseph B Margolick; Jay H Bream; Otoniel Martínez-Maza; Joe Lopez; Xiuhong Li; John P Phair; Susan L Koletar; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

5.  Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy.

Authors:  Kristine M Erlandson; Kunling Wu; Susan L Koletar; Robert C Kalayjian; Ronald J Ellis; Babafemi Taiwo; Frank J Palella; Katherine Tassiopoulos
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

6.  Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study.

Authors:  Giuseppe Sergi; Nicola Veronese; Luigi Fontana; Marina De Rui; Francesco Bolzetta; Sabina Zambon; Maria-Chiara Corti; Giovannella Baggio; Elena Debora Toffanello; Gaetano Crepaldi; Egle Perissinotto; Enzo Manzato
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

7.  Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.

Authors:  Kathleen V Fitch; Suman Srinivasa; Suhny Abbara; Tricia H Burdo; Kenneth C Williams; Peace Eneh; Janet Lo; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

8.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Authors:  Virginia A Triant; Hang Lee; Colleen Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

9.  Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.

Authors:  Katherine Tassiopoulos; Mona Abdo; Kunling Wu; Susan L Koletar; Frank J Palella; Robert Kalayjian; Babafemi Taiwo; Kristine M Erlandson
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

10.  Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction.

Authors:  Atul Anand; Sarah Cudmore; Shirley Robertson; Jacqueline Stephen; Kristin Haga; Christopher J Weir; Scott A Murray; Kirsty Boyd; Julian Gunn; Javaid Iqbal; Alasdair MacLullich; Susan D Shenkin; Keith A A Fox; Nicholas Mills; Martin A Denvir
Journal:  BMC Geriatr       Date:  2020-03-13       Impact factor: 3.921

View more
  1 in total

1.  Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.

Authors:  Kristine M Erlandson; Kathleen V Fitch; Sara A McCallum; Heather J Ribaudo; Edgar T Overton; Markella V Zanni; Gerald S Bloomfield; Todd T Brown; Carl J Fichtenbaum; Sara Bares; Judith A Aberg; Pamela S Douglas; Evelynne S Fulda; Jorge L Santana-Bagur; Jose G Castro; Laura E Moran; Vidya Mave; Khuanchai Supparatpinyo; Ponego L Ponatshego; Mauro Schechter; Steven K Grinspoon
Journal:  Clin Infect Dis       Date:  2022-09-30       Impact factor: 20.999

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.